Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 7 | 6 | 5 | 16 | 9 |
| Gross Profit | 7 | 6 | 5 | 16 | 9 |
| Operating Expenses | 2,496 | 1,866 | 1,720 | 2,159 | 2,076 |
| Operating Income | -2,489 | -1,860 | -1,715 | -2,143 | -2,067 |
| Interest Expense | 98 | 76 | 57 | 45 | 43 |
| Other Income | -199 | -121 | -61 | -70 | -377 |
| Pre-tax Income | -2,786 | -2,057 | -1,834 | -2,258 | -2,487 |
| Net Income Continuous | -2,786 | -2,057 | -1,834 | -2,258 | -2,487 |
| Net Income | $-2,786 | $-2,057 | $-1,834 | $-2,258 | $-2,487 |
| EPS Basic Total Ops | -1,866.67 | -1,400.00 | -1,433.33 | -1,866.67 | -2,300.00 |
| EPS Basic Continuous Ops | -1,862.76 | -1,415.09 | -1,427.25 | -1,878.73 | -2,290.36 |
| EPS Diluted Total Ops | -1,866.67 | -1,400.00 | -1,433.33 | -1,866.67 | -2,300.00 |
| EPS Diluted Continuous Ops | -1,862.76 | -1,415.09 | -1,427.25 | -1,878.73 | -2,290.36 |
| EBITDA(a) | $-2,292 | $-1,689 | $-1,614 | $-2,013 | $-1,668 |